These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36889545)

  • 21. TSPO expression in a Zika virus murine infection model as an imaging target for acute infection-induced neuroinflammation.
    Victorio CBL; Msallam R; Novera W; Ong J; Yang TJ; Ganasarajah A; Low J; Watanabe S; Chacko AM
    Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):742-755. PubMed ID: 36348095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroinflammation in Parkinson's disease: a meta-analysis of PET imaging studies.
    Zhang PF; Gao F
    J Neurol; 2022 May; 269(5):2304-2314. PubMed ID: 34724571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations.
    Tronel C; Largeau B; Santiago Ribeiro MJ; Guilloteau D; Dupont AC; Arlicot N
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applications of PET and SPECT in Patients with Autism Spectrum Disorder.
    Martini AL; Quartuccio N; Schiera IG; Berti V; Burroni L; Cistaro A
    Curr Med Imaging; 2024; 20():1-11. PubMed ID: 38389341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central nervous system expression and PET imaging of the translocator protein in relapsing-remitting experimental autoimmune encephalomyelitis.
    Mattner F; Staykova M; Berghofer P; Wong HJ; Fordham S; Callaghan P; Jackson T; Pham T; Gregoire MC; Zahra D; Rahardjo G; Linares D; Katsifis A
    J Nucl Med; 2013 Feb; 54(2):291-8. PubMed ID: 23321458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease.
    Best L; Ghadery C; Pavese N; Tai YF; Strafella AP
    Curr Neurol Neurosci Rep; 2019 Apr; 19(5):24. PubMed ID: 30941587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging neuroinflammation with TSPO: A new perspective on the cellular sources and subcellular localization.
    Guilarte TR; Rodichkin AN; McGlothan JL; Acanda De La Rocha AM; Azzam DJ
    Pharmacol Ther; 2022 Jun; 234():108048. PubMed ID: 34848203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases.
    Dupont AC; Largeau B; Santiago Ribeiro MJ; Guilloteau D; Tronel C; Arlicot N
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Convergent evidence for mGluR5 in synaptic and neuroinflammatory pathways implicated in ASD.
    Zantomio D; Chana G; Laskaris L; Testa R; Everall I; Pantelis C; Skafidas E
    Neurosci Biobehav Rev; 2015 May; 52():172-7. PubMed ID: 25704074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of neuroinflammation in Autism Spectrum Disorder.
    Matta SM; Hill-Yardin EL; Crack PJ
    Brain Behav Immun; 2019 Jul; 79():75-90. PubMed ID: 31029798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [
    Jucaite A; Cselényi Z; Kreisl WC; Rabiner EA; Varrone A; Carson RE; Rinne JO; Savage A; Schou M; Johnström P; Svenningsson P; Rascol O; Meissner WG; Barone P; Seppi K; Kaufmann H; Wenning GK; Poewe W; Farde L
    Mov Disord; 2022 Jan; 37(1):119-129. PubMed ID: 34609758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders.
    Werry EL; Bright FM; Piguet O; Ittner LM; Halliday GM; Hodges JR; Kiernan MC; Loy CT; Kril JJ; Kassiou M
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developmental microglial priming in postmortem autism spectrum disorder temporal cortex.
    Lee AS; Azmitia EC; Whitaker-Azmitia PM
    Brain Behav Immun; 2017 May; 62():193-202. PubMed ID: 28159644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic review of molecular imaging (PET and SPECT) in autism spectrum disorder: current state and future research opportunities.
    Zürcher NR; Bhanot A; McDougle CJ; Hooker JM
    Neurosci Biobehav Rev; 2015 May; 52():56-73. PubMed ID: 25684726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C]vinpocetine.
    Gulyás B; Vas A; Tóth M; Takano A; Varrone A; Cselényi Z; Schain M; Mattsson P; Halldin C
    Neuroimage; 2011 Jun; 56(3):1111-21. PubMed ID: 21320609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential crosstalk between sonic hedgehog-WNT signaling and neurovascular molecules: Implications for blood-brain barrier integrity in autism spectrum disorder.
    Gozal E; Jagadapillai R; Cai J; Barnes GN
    J Neurochem; 2021 Oct; 159(1):15-28. PubMed ID: 34169527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Imaging of Neuroinflammation in Idiopathic Parkinson's Disease.
    Roussakis AA; Piccini P
    Int Rev Neurobiol; 2018; 141():347-363. PubMed ID: 30314603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased expression of mGluR5 within the dorsolateral prefrontal cortex in autism and increased microglial number in mGluR5 knockout mice: Pathophysiological and neurobehavioral implications.
    Chana G; Laskaris L; Pantelis C; Gillett P; Testa R; Zantomio D; Burrows EL; Hannan AJ; Everall IP; Skafidas E
    Brain Behav Immun; 2015 Oct; 49():197-205. PubMed ID: 26052099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroinflammation in Huntington's Disease: New Insights with
    Lois C; González I; Izquierdo-García D; Zürcher NR; Wilkens P; Loggia ML; Hooker JM; Rosas HD
    ACS Chem Neurosci; 2018 Nov; 9(11):2563-2571. PubMed ID: 29719953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microglia imaging in methamphetamine use disorder: a positron emission tomography study with the 18 kDa translocator protein radioligand [F-18]FEPPA.
    Rathitharan G; Truong J; Tong J; McCluskey T; Meyer JH; Mizrahi R; Warsh J; Rusjan P; Kennedy JL; Houle S; Kish SJ; Boileau I
    Addict Biol; 2021 Jan; 26(1):e12876. PubMed ID: 32017280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.